Results 161 to 170 of about 4,781 (281)

Sustainable recovery of a chitin–glucan complex–protein biocomposite from yeast biomass using biocompatible ionic liquids

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Chitin–glucan complex (CGC) is typically extracted from fungal or yeast biomass using harsh alkaline treatments that not only generate high‐salt, organic‐rich effluents, but also negatively impact the structural and functional properties of the recovered copolymer, while wasting the yeast protein fraction, which is discarded.
Inês C. Ferreira, Cristiana A. V. Torres, Carlos A. M. Afonso, Luísa A. Neves, Filomena Freitas   +4 more
wiley   +1 more source

[Epidemiologic and clinical profile, 90 days survival of incident end stage renal patient in haemodialysis during SARS-CoV2 pandemic: Experience of the General Hospital of Douala]. [PDF]

Nephrol Ther, 2021
Fouda Menye Epse Ebana HD, Halle MP, Mbele Onana C, Mbatchou BH, Luma Namme H, Ashuntantang Enow G.   +5 more
europepmc   +1 more source

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment

British Journal of Clinical Pharmacology, EarlyView.
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, Jia Miao   +6 more
wiley   +1 more source

[Psychological impact of lockdown and the COVID-19 epidemic on haemodialysis patients and carers in France]. [PDF]

Nephrol Ther, 2021
Guerraoui A, Idier L, Hallonet P, Dolley-Hitze T, Gosselin M, Duneau G, Vendrely B, Hirigoyen MD, Azzouz L, Bouillier M, Pelletier S, Fouque D, Fessi H, De-Precigout V, Vigneau C, Kolko A, Pinçon É, Duquennoy S, Delezire A, Chantrel F, Combe C, Chauveau P, Caillette-Beaudoin A, Lasseur C, Prézelin-Reydit M.   +24 more
europepmc   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

Hydrogel Embedding of Mesenchymal Stem Cells Supports Extracellular Vesicle Production

Biotechnology and Bioengineering, EarlyView.
This study investigates the effects of 3D culture conditions on extracellular vesicle (EV) production by mesenchymal stem cells (MSCs) in a gelatin‐based hydrogel matrix (GelMA). The EVs from both conditions were found to have similar morphological, molecular, and functional properties, but 3D cultures produced more total EVs per volume.
Rachel K. Moen, Gabriella Faircloth, Nicole T. Marguerite, Mariachiara Conti, Ethan S. Lippmann, Jamey D. Young   +5 more
wiley   +1 more source

Home Sweet Home: A Program Report on Promoting the Uptake of Home Dialysis. [PDF]

Can J Kidney Health Dis
Churchill LJ, Reintjes F, Pauly R, Shah N, Thompson S.   +4 more
europepmc   +1 more source